Adult Spinal DeformityNCT04888104
Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients
An observational study of Adult Spinal Deformity and Scoliosis, run by International Spine Study Group Foundation at 9 sites in United States.
Trial summary
Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Adult Spinal Deformity, Scoliosis, Kyphosis
- What is being tested?
- Index or revision spine surgery for complex adult spinal deformity
- Type of treatment
- Surgery or procedure
- How many people
- 225 participants
- Where
- 9 sitesUnited States
- Study dates
- 9 Jul 2021to 31 Dec 2034
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Adult, Older adult
Study population: Multicenter, prospective, observational, study evaluating the safety and performance of the VersaTie System by comparing adult patients receiving minimum 5 level posterior spinal fusion with pedicle screw fixation supplemented at the proximal aspect of the construct with the VersaTie System
Who may be able to join
- >18 years of age at the time of treatment
- EOS full body or standing 36" AP \& Lateral images of entire spine
- Posterior spine fusion with pedicle screw fixation construct of 5 or more levels
- Pedicle screw fixation to be supplemented proximally with NuVasive VersaTie system
- Upper instrumented vertebra (UIV) terminating at a newly instrumented level
- Lowest instrumented vertebra (LIV) sacrum/pelvis
- Surgery scheduled to take place in the next 6 months
Who cannot join
- Active spine tumor or infection
- Deformity due to acute trauma
- Prisoners
- Women who are pregnant
- Patient is unwilling or unable to complete questionnaires
Trial locations and contacts
9 sites in 1 country. Contact the study team or a site near you to ask about taking part.
Ray Pinteric contact
9 sites in 1 country
United States9 sites, 8 recruiting
- Recruiting
University at Buffalo, Department of Neurosurgery
Buffalo, New York, 14260-1660
Nicole Armstrong, narmstrong@ubns.com
Jeffrey Mullin, MD
- Recruiting
University of Virginia
Charlottesville, Virginia, 22908
Lorrie Sipe, 434-924-8875, lag3k@virginia.edu
Justin Smith, MD
- Recruiting
Presbyterian/St. Luke's Medical Center
Denver, Colorado, 80218
Bret Line, breton.line@gmail.com
Shay Bess
- Not yet recruiting
Duke University Health System
Durham, North Carolina, 27708
Ronald Pegues, ronald.pegues@duke.edu
Christopher I Shaffrey, MD
- Recruiting
Shiley Center for Orthopaedic Research and Education at Scripps Clinic
La Jolla, California, 92037
Paulina de la Garza, 858-554-7124, delaGarza.Paulina@scrippshealth.org
Gregory Mundis, MD
- Recruiting
New York University, Department of Orthopedic Surgery
New York, New York, 10003
Connie Maglaras, constance.maglaras@nyulangone.org
Themistocles Protopsaltis, MD
- Recruiting
Barrow Neurological Institute
Phoenix, Arizona, 85013
Caleb Fisher, caleb.fisher900@commonspirit.org
Jay Turner, MD
- Withdrawn
University of California - San Francisco
San Francisco, California, 94143
- Recruiting
Louisiana Spine Institute
Shreveport, Louisiana, 71101
Cody McConnell, CMcConnell@louisianaspine.org
Pierce Nunley, MD
About this study
Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients
Read the detailed description
Specific Aims:
- Evaluate the safety and performance of posterior spinal fusion constructs supplemented with posterior spinolaminar fixation using the VersaTie System compared to posterior fixation constructs without VersaTie System supplementation in adult patients undergoing long posterior spinal fusion by evaluating intraoperative and postoperative complications, clinical and radiographic outcomes, patient-reported outcomes (PROs) and need for revision surgery.
- Evaluate surgical treatment outcomes and identify best practice guidelines for complex adult spinal deformity (ASD) patients, including radiographic and clinical outcomes, surgical and postoperative complications, risk factors for and revision surgery.
- Develop and validate a standardized, universal complications classification system for spine surgery
- Evaluate perioperative blood management approaches, transfusion requirements, including variance in thresholds for blood transfusion and associated complications for adult spinal deformity surgery
- Assess impact of opioid use and pain management on patient cost, complications and outcomes
- Evaluate optimal opioid and analgesic usage and protocols for standard work development
- Evaluate clinical outcomes utilizing legacy patient reported outcome measures (PROMs) including modified Oswestry Disability Index (mODI), Scoliosis Research Society Questionnaire 22r (SRS-22r), Veterans RAND-12 (VR-12), and numeric pain rating scale (NRS) and compare the results of these legacy PROMs to outcomes scores as measured by the NIH Patient Reported Outcomes Measurement Information System (PROMIS) - PROMIS Anxiety, Depression, Pain Interference, Physical Function, and Social Satisfaction. Secondary aims for PROM research for this study include
- Validation of the PROMIS tool for ASD
- Establish a core set of PROMs for best practice guidelines for ASD
- Evaluate patient reported outcome variance for ASD according to SRS-Schwab spine deformity type including variance in baseline PROM domains impacted and variance in improvement in PROM domains
- Evaluate ASD outcomes compared to population norms and investigate/develop appropriate measures of clinically significant improvement
- Evaluate clinical outcomes stratifying by patient chronological and physiological age
- Evaluate measures to quantify patient physiological age including patient frailty for ASD and validate a frailty measurement system for ASD
- Evaluate the role of functional tests in patient's baseline frailty assessment including hand manometer and Edmonton Frail Scale. See appendix, pages 17 \& 18 for details.
- Evaluate the contribution of patient frailty to patient outcomes, complications, cost of care, disability, and complications
- Evaluate if patient frailty is a static measure or if frailty is a dynamic measure that can be improved through "pre-habilitation" and if the according associations with reductions in frailty correlate with reductions of cost, complications, and improvement in outcomes
- Evaluate cost variance for ASD surgery according to patient, institution, and geographical region and evaluate the cost effectiveness of surgical intervention for ASD
- Evaluate incidence of and risk factors for mental health (MH) compromise among ASD patients and establish best practice guidelines for assessing MH for ASD patients
- Evaluate the association of MH with surgical complications, outcomes, hospital length of stay and cost for ASD surgery
- Evaluate the association of social health surgical complications, outcomes, hospital length of stay and cost for ASD surgery and risk factors for routine (home) discharge vs. skilled nursing facility (SNF)/rehabilitation facility
- Broaden the evaluation of the surgically treated ASD patient to maximize evaluation of the entirety of the episode of care to include steps that can be taken prior to surgery including "prehabilitation," pain management, and MH care to improve treatment outcomes, reduce cost, reduce hospital length of stay, reduce non-routing discharge and reduce early and late complications
- Establish a core set of standard work guidelines to clinically and radiographically evaluate and treat ASD patients and evaluate the utility of standard work to improve outcomes for ASD and formulate best practice guidelines for surgical treatment of ASD
- Develop predictive analytic algorithms to risk stratify for best/worst outcomes, complications, sentinel events, and economic loss for ASD surgery
- Evaluate the prevalence and incidence of sacroiliac pain before/after complex adult spinal deformity surgery.
- Conditions
- Adult Spinal Deformity, Scoliosis, Kyphosis
- Being tested
- Index or revision spine surgery for complex adult spinal deformity
- Keywords
- Scoliosis, Kyphosis, Sagittal Imbalance
- Medical subject headings
- Scoliosis, Kyphosis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Index or revision spine surgery for complex adult spinal deformityProcedure or surgery
Also called VersaTie System
Adult patients receiving minimum 5 level posterior spinal fusion with pedicle screw fixation supplemented at the proximal aspect of the construct with the VersaTie System.
| Study group | Role | What they receive |
|---|---|---|
| VersaTie | Not described Receives: Procedure: Index or revision spine surgery for complex adult spinal deformity |
What is being measured
The primary outcome is the main question the study is designed to answer.
Scoliosis Research Society (SRS) 22r
Scoliosis specific patient reported outcome
Measured: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
Oswestry
Spine specific patient reported outcome
Measured: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
Veterans RAND 12 Item Health Survey (VR-12)
Patient reported outcome
Measured: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
Patient-Reported Outcome Measurement Information System (PROMIS) - Anxiety
Patient reported outcome
Measured: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
Patient-Reported Outcome Measurement Information System (PROMIS) - Depression
Patient reported outcome
Measured: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
Patient-Reported Outcome Measurement Information System (PROMIS) - Pain Interference
Patient reported outcome
Measured: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
Patient-Reported Outcome Measurement Information System (PROMIS) - Physical Function
Patient reported outcome
Measured: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
Patient-Reported Outcome Measurement Information System (PROMIS) - Social Satisfaction
Patient reported outcome
Measured: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
Patient-Reported Outcome Measurement Information System (PROMIS) - Social Role
Patient reported outcome
Measured: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
Visual Analog Scale - Back Pain
Self-reported back pain on scale of 0 (No pain) to 10 (severe pain)
Measured: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
Visual Analog Scale - Leg Pain
Self-reported leg pain on scale of 0 (No pain) to 10 (severe pain)
Measured: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
Secondary outcomes (3)
Edmonton Frail Scale
Evaluate frailty on scale of 0 to 17 where higher scores mean more frail
Measured: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
Canadian Study of Health and Aging (CSHA)
Frailty scale of 1 to 9; higher scores mean more frail
Measured: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
Adverse Events
Occurrence of Adverse events meeting reporting criteria and their relationship to intervention throughout the study
[Time Frame: 3 months and 1, 2, 5 \& 10 year post treatment]
Measured: 3 months and 1, 2, 5 & 10 year post treatment
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 May 2021
- Study start9 Jul 2021
- Primary completion31 Dec 2031 (estimated)
- Study completion31 Dec 2034 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Adult Spinal DeformityStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 225 participants (estimated)
Sponsor and investigators
- Lead sponsor
- International Spine Study Group Foundation
- Sponsor type
- University, hospital or other
- Collaborators
- NuVasive
- Responsible party
- Sponsor
- Investigators
- Shay Bess, MD, Principal investigator, Presbyterian/St Luke's Medical CenterJeffrey Mullin, MD, Principal investigator, University at Buffalo, Department of NeurosurgeryChristopher Shaffrey, MD, Principal investigator, Duke University Medical Center, Section of Spine SurgeryJustin Smith, MD, Principal investigator, University of Virginia Medical Center, Department of Neurosurgery
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04888104
- Sponsor's protocol ID
- 2139
- Status last verified
- Feb 2026
- First submitted
- 11 May 2021
- Last updated
- 17 Feb 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- Yes
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 17 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients
- ClinicalTrials.gov ID
- NCT04888104
- Acronym / sponsor ID
- 2139
- Conditions
- Adult Spinal Deformity, Scoliosis, Kyphosis
- Keywords
- Scoliosis, Kyphosis, Sagittal Imbalance
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 225 participants (estimated)
- Lead sponsor
- International Spine Study Group FoundationUniversity, hospital or other
- Collaborators
- NuVasive
- Study start
- 9 Jul 2021 (actual)
- Primary completion
- 31 Dec 2031 (estimated)
- Study completion
- 31 Dec 2034 (estimated)
- First posted
- 17 May 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients
Detailed description
Specific Aims:
- Evaluate the safety and performance of posterior spinal fusion constructs supplemented with posterior spinolaminar fixation using the VersaTie System compared to posterior fixation constructs without VersaTie System supplementation in adult patients undergoing long posterior spinal fusion by evaluating intraoperative and postoperative complications, clinical and radiographic outcomes, patient-reported outcomes (PROs) and need for revision surgery.
- Evaluate surgical treatment outcomes and identify best practice guidelines for complex adult spinal deformity (ASD) patients, including radiographic and clinical outcomes, surgical and postoperative complications, risk factors for and revision surgery.
- Develop and validate a standardized, universal complications classification system for spine surgery
- Evaluate perioperative blood management approaches, transfusion requirements, including variance in thresholds for blood transfusion and associated complications for adult spinal deformity surgery
- Assess impact of opioid use and pain management on patient cost, complications and outcomes
- Evaluate optimal opioid and analgesic usage and protocols for standard work development
- Evaluate clinical outcomes utilizing legacy patient reported outcome measures (PROMs) including modified Oswestry Disability Index (mODI), Scoliosis Research Society Questionnaire 22r (SRS-22r), Veterans RAND-12 (VR-12), and numeric pain rating scale (NRS) and compare the results of these legacy PROMs to outcomes scores as measured by the NIH Patient Reported Outcomes Measurement Information System (PROMIS) - PROMIS Anxiety, Depression, Pain Interference, Physical Function, and Social Satisfaction. Secondary aims for PROM research for this study include
- Validation of the PROMIS tool for ASD
- Establish a core set of PROMs for best practice guidelines for ASD
- Evaluate patient reported outcome variance for ASD according to SRS-Schwab spine deformity type including variance in baseline PROM domains impacted and variance in improvement in PROM domains
- Evaluate ASD outcomes compared to population norms and investigate/develop appropriate measures of clinically significant improvement
- Evaluate clinical outcomes stratifying by patient chronological and physiological age
- Evaluate measures to quantify patient physiological age including patient frailty for ASD and validate a frailty measurement system for ASD
- Evaluate the role of functional tests in patient's baseline frailty assessment including hand manometer and Edmonton Frail Scale. See appendix, pages 17 \& 18 for details.
- Evaluate the contribution of patient frailty to patient outcomes, complications, cost of care, disability, and complications
- Evaluate if patient frailty is a static measure or if frailty is a dynamic measure that can be improved through "pre-habilitation" and if the according associations with reductions in frailty correlate with reductions of cost, complications, and improvement in outcomes
- Evaluate cost variance for ASD surgery according to patient, institution, and geographical region and evaluate the cost effectiveness of surgical intervention for ASD
- Evaluate incidence of and risk factors for mental health (MH) compromise among ASD patients and establish best practice guidelines for assessing MH for ASD patients
- Evaluate the association of MH with surgical complications, outcomes, hospital length of stay and cost for ASD surgery
- Evaluate the association of social health surgical complications, outcomes, hospital length of stay and cost for ASD surgery and risk factors for routine (home) discharge vs. skilled nursing facility (SNF)/rehabilitation facility
- Broaden the evaluation of the surgically treated ASD patient to maximize evaluation of the entirety of the episode of care to include steps that can be taken prior to surgery including "prehabilitation," pain management, and MH care to improve treatment outcomes, reduce cost, reduce hospital length of stay, reduce non-routing discharge and reduce early and late complications
- Establish a core set of standard work guidelines to clinically and radiographically evaluate and treat ASD patients and evaluate the utility of standard work to improve outcomes for ASD and formulate best practice guidelines for surgical treatment of ASD
- Develop predictive analytic algorithms to risk stratify for best/worst outcomes, complications, sentinel events, and economic loss for ASD surgery
- Evaluate the prevalence and incidence of sacroiliac pain before/after complex adult spinal deformity surgery.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| VersaTie | – | Procedure: Index or revision spine surgery for complex adult spinal deformity |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Age groups
- Adult, Older adult
- Study population
- Multicenter, prospective, observational, study evaluating the safety and performance of the VersaTie System by comparing adult patients receiving minimum 5 level posterior spinal fusion with pedicle screw fixation supplemented at the proximal aspect of the construct with the VersaTie System
Key inclusion criteria (7 listed)
- >18 years of age at the time of treatment
- EOS full body or standing 36" AP \& Lateral images of entire spine
- Posterior spine fusion with pedicle screw fixation construct of 5 or more levels
- Pedicle screw fixation to be supplemented proximally with NuVasive VersaTie system
- Upper instrumented vertebra (UIV) terminating at a newly instrumented level
Key exclusion criteria (5 listed)
- Active spine tumor or infection
- Deformity due to acute trauma
- Prisoners
- Women who are pregnant
- Patient is unwilling or unable to complete questionnaires
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Index or revision spine surgery for complex adult spinal deformityAlso: VersaTie SystemAdult patients receiving minimum 5 level posterior spinal fusion with pedicle screw fixation supplemented at the proximal aspect of the construct with the VersaTie System. | Procedure or surgery | VersaTie |
Primary outcome
Scoliosis Research Society (SRS) 22r
Time frame: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
Scoliosis specific patient reported outcome
Oswestry
Time frame: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
Spine specific patient reported outcome
Veterans RAND 12 Item Health Survey (VR-12)
Time frame: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
Patient reported outcome
Patient-Reported Outcome Measurement Information System (PROMIS) - Anxiety
Time frame: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
Patient reported outcome
Patient-Reported Outcome Measurement Information System (PROMIS) - Depression
Time frame: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
Patient reported outcome
Patient-Reported Outcome Measurement Information System (PROMIS) - Pain Interference
Time frame: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
Patient reported outcome
Patient-Reported Outcome Measurement Information System (PROMIS) - Physical Function
Time frame: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
Patient reported outcome
Patient-Reported Outcome Measurement Information System (PROMIS) - Social Satisfaction
Time frame: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
Patient reported outcome
Patient-Reported Outcome Measurement Information System (PROMIS) - Social Role
Time frame: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
Patient reported outcome
Visual Analog Scale - Back Pain
Time frame: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
Self-reported back pain on scale of 0 (No pain) to 10 (severe pain)
Visual Analog Scale - Leg Pain
Time frame: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
Self-reported leg pain on scale of 0 (No pain) to 10 (severe pain)
3 secondary outcomes
Edmonton Frail Scale
Time frame: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
Canadian Study of Health and Aging (CSHA)
Time frame: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
Adverse Events
Time frame: 3 months and 1, 2, 5 & 10 year post treatment
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Feb 2026.
- Individual participant dataSharing planned: No
Related trials for Adult Spinal Deformity
Active, not recruiting
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
Neuromuscular Diseases (NMD), Amyotrophic Lateral Sclerosis
Recruiting
High-Tech Rehabilitation Pathway for Chronic Adult Neuromuscular Diseases - Fit4MedRob-Chronic MND Project
Amyotrophic Lateral Sclerosis, Chronic Inflammatory Demyelinating Neuropathy
RecruitingObservational study
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Rare Disorders, Undiagnosed Disorders
Recruiting
Quality of Life, Psychosocial Burden, and Structural-functional Status in Adults With Spinal Deformity.
ASD, Scoliosis Idiopathic Adolescent
Not yet recruitingPhase 1
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ATI-105 in Healthy Adults
Friedreich Ataxia, Cardiomyopathies
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Ray Pinteric contact
Shay Bess, MD principal investigator
Presbyterian/St Luke's Medical Center
Jeffrey Mullin, MD principal investigator
University at Buffalo, Department of Neurosurgery
Christopher Shaffrey, MD principal investigator
Duke University Medical Center, Section of Spine Surgery
9 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Adult Spinal Deformity and Scoliosis, run by International Spine Study Group Foundation at 9 sites in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 17 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 9 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Christine Baldus, MH (6184444130, baldusc@wustl.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Scoliosis Research Society (SRS) 22r (time frame: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up). The study lists 11 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Feb 2026.